Śpiewak, D.;                     Drzyzga, Ł.;                     Dorecka, M.;                     Witek, K.;                     Wyględowska-Promieńska, D.    
        Efficacy of Faricimab in the Treatment of Diabetic Macular Edema and Faricimab-Related Changes in OCT and OCT Angiography. Pharmaceutics 2025, 17, 858.
    https://doi.org/10.3390/pharmaceutics17070858
    AMA Style
    
                                Śpiewak D,                                 Drzyzga Ł,                                 Dorecka M,                                 Witek K,                                 Wyględowska-Promieńska D.        
                Efficacy of Faricimab in the Treatment of Diabetic Macular Edema and Faricimab-Related Changes in OCT and OCT Angiography. Pharmaceutics. 2025; 17(7):858.
        https://doi.org/10.3390/pharmaceutics17070858
    
    Chicago/Turabian Style
    
                                Śpiewak, Dorota,                                 Łukasz Drzyzga,                                 Mariola Dorecka,                                 Katarzyna Witek,                                 and Dorota Wyględowska-Promieńska.        
                2025. "Efficacy of Faricimab in the Treatment of Diabetic Macular Edema and Faricimab-Related Changes in OCT and OCT Angiography" Pharmaceutics 17, no. 7: 858.
        https://doi.org/10.3390/pharmaceutics17070858
    
    APA Style
    
                                Śpiewak, D.,                                 Drzyzga, Ł.,                                 Dorecka, M.,                                 Witek, K.,                                 & Wyględowska-Promieńska, D.        
        
        (2025). Efficacy of Faricimab in the Treatment of Diabetic Macular Edema and Faricimab-Related Changes in OCT and OCT Angiography. Pharmaceutics, 17(7), 858.
        https://doi.org/10.3390/pharmaceutics17070858